- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
3D Medicines Biotechnology Shanghai Co Ltd (1244)
3D Medicines Biotechnology Shanghai Co Ltd stock price live, this page displays HK 1244 stock exchange data. View the 1244 premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the 3D Medicines Biotechnology Shanghai Co Ltd real time stock price chart below.
What Is the 3D Medicines Biotechnology Shanghai Co Ltd Stock Price Today?
The 3D Medicines Biotechnology Shanghai Co Ltd stock price today is 7.77.
What Is the Stock Symbol for 3D Medicines Biotechnology Shanghai Co Ltd?
The stock symbol for 3D Medicines Biotechnology Shanghai Co Ltd is ""1244.""
What Stock Exchange Does 3D Medicines Biotechnology Shanghai Co Ltd Trade On?
3D Medicines Biotechnology Shanghai Co Ltd is listed and trades on the Hong Kong stock exchange.
Is 3D Medicines Biotechnology Shanghai Co Ltd a Good Stock to Buy?
Determining whether 3D Medicines Biotechnology Shanghai Co Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 1244 quote. (ISIN: KYG8872R1011)
What Is the 3D Medicines Biotechnology Shanghai Co Ltd Stock Price Today?
The 3D Medicines Biotechnology Shanghai Co Ltd stock price today is 7.77.
What Is the Stock Symbol for 3D Medicines Biotechnology Shanghai Co Ltd?
The stock symbol for 3D Medicines Biotechnology Shanghai Co Ltd is ""1244.""
What Stock Exchange Does 3D Medicines Biotechnology Shanghai Co Ltd Trade On?
3D Medicines Biotechnology Shanghai Co Ltd is listed and trades on the Hong Kong stock exchange.
Is 3D Medicines Biotechnology Shanghai Co Ltd a Good Stock to Buy?
Determining whether 3D Medicines Biotechnology Shanghai Co Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 1244 quote. (ISIN: KYG8872R1011)
Hong Kong
Currency in HKD
7.77
-0.18(-2.26%)
Closed·
Fair Value
An estimate of a 3D Medicines Biotechnology Shanghai's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
7.15
7.90
52 wk Range
1.60
8.85
1244 Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
1244 is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a 3D Medicines Biotechnology Shanghai's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
7.157.90
52 wk Range
1.608.85
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
1244 Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a 3D Medicines Biotechnology Shanghai's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Neutral
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Impressive gross profit margins
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell
3D Medicines Biotechnology Shanghai Co Ltd Company Profile
3D Medicines Inc., a biopharmaceutical company, researches, develops, and commercializes oncology products and other drug candidates for the treatment of patients with various cancers in the People’s Republic of China. The company offers Envafolimab, a PD-L1 antibody in the form of subcutaneous injection for the treatment of previously treated microsatellite instability-high (MSI-H)/mismatch repair deficient(dMMR) advanced solid tumors. It is also developing Envafolimab, which is in Phase III clinical trials for advanced BTC and NSCLC; and in Phase II clinical trials G/GEJ and TMB-H advanced cancer, EC, HCC, CRC, NSCLC, microsatellite stable CRC, and dMMR advanced sold tumors. In addition, it provides products which is in development pipeline include 3D189 for multi-indication tumor that has completed Phase I and is in phase III clinical trial for the treatment of acute myeloid leukemia (AML); 3D1001 for the treatment of post-surgical dental pain/cancer pain which is in phase II trial; 3D1002 for cancer pain/osteoarthritis and is in phase II trial; 3D229 (GAS6/AXL) for the treatment of acute myeloid leukemia (AML), kidney cancer, pancreatic cancer, breast cancer, lung cancer, ovarian cancer, and prostate cancer and has completed phase I clinical trial; and 3D185, which is in phase I clinical trial for the treatment of locally advanced or metastatic solid tumors, as well as other products, such as 3D197 for multi-indication tumor immunotherapy that is in Phase I clinical trial; 3D011 for advanced malignant solid tumor which is in Phase I clinical trial; and 3D057, 3D059, 3D1015, 3D124, 3D060, and 3D062 for multiple indications tumors. 3D Medcines Inc. was founded in 2014 and is headquartered in Qingdao, China.
Compare 1244 to Peers and Sector
Metrics to compare | 1244 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship1244PeersSector | |
|---|---|---|---|---|
P/E Ratio | −9.6x | −21.8x | −0.5x | |
PEG Ratio | −0.14 | 0.18 | 0.00 | |
Price/Book | 2.2x | 6.3x | 2.6x | |
Price / LTM Sales | 3.9x | 20.7x | 3.3x | |
Upside (Analyst Target) | - | −10.2% | 38.7% | |
Fair Value Upside | Unlock | −12.3% | 5.0% | Unlock |
Earnings
Latest Release
Apr 30, 2025
EPS / Forecast
-0.32 / --
Revenue / Forecast
239.23M / --
FAQ
What Stock Exchange Does 3D Medicines Biotechnology Shanghai Trade On?
3D Medicines Biotechnology Shanghai is listed and trades on the Hong Kong Stock Exchange stock exchange.
What Is the Stock Symbol for 3D Medicines Biotechnology Shanghai?
The stock symbol for 3D Medicines Biotechnology Shanghai is "1244."
What Is the 3D Medicines Biotechnology Shanghai Market Cap?
As of today, 3D Medicines Biotechnology Shanghai market cap is 2.04B.
What Is 3D Medicines Biotechnology Shanghai's Earnings Per Share (TTM)?
The 3D Medicines Biotechnology Shanghai EPS (TTM) is -0.75.
From a Technical Analysis Perspective, Is 1244 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
How Many Times Has 3D Medicines Biotechnology Shanghai Stock Split?
3D Medicines Biotechnology Shanghai has split 0 times.
How Many Employees Does 3D Medicines Biotechnology Shanghai Have?
3D Medicines Biotechnology Shanghai has 191 employees.
What is the current trading status of 3D Medicines Biotechnology Shanghai (1244)?
As of 27 Aug 2025, 3D Medicines Biotechnology Shanghai (1244) is trading at a price of 7.77, with a previous close of 7.77. The stock has fluctuated within a day range of 7.15 to 7.90, while its 52-week range spans from 1.60 to 8.85.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.